Canada markets open in 3 hours 55 minutes

Hemagen Diagnostics, Inc. (HMGN)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00000.0000 (0.00%)
At close: 02:25PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 441.76k
Enterprise Value 441.76k
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.10
Price/Book (mrq)N/A
Enterprise Value/Revenue 0.11
Enterprise Value/EBITDA -1.61

Trading Information

Stock Price History

Beta (5Y Monthly) 0.22
52-Week Change 30.00%
S&P500 52-Week Change 325.59%
52 Week High 30.0001
52 Week Low 30.0000
50-Day Moving Average 30.0001
200-Day Moving Average 30.0001

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 515.5M
Implied Shares Outstanding 63.88B
Float 8N/A
% Held by Insiders 10.00%
% Held by Institutions 10.00%
Shares Short (Mar 11, 2003) 4N/A
Short Ratio (Mar 11, 2003) 40.11
Short % of Float (Mar 11, 2003) 4N/A
Short % of Shares Outstanding (Mar 11, 2003) 40.00%
Shares Short (prior month Jan 10, 2003) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Sept 30, 2012
Most Recent Quarter (mrq)Sept 30, 2012

Profitability

Profit Margin -22.45%
Operating Margin (ttm)-4.99%

Management Effectiveness

Return on Assets (ttm)-10.27%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)4.04M
Revenue Per Share (ttm)0.26
Quarterly Revenue Growth (yoy)-23.60%
Gross Profit (ttm)N/A
EBITDA -273.66k
Net Income Avi to Common (ttm)-907.32k
Diluted EPS (ttm)-0.0000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)66.29k
Total Cash Per Share (mrq)0
Total Debt (mrq)5.03M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.07
Book Value Per Share (mrq)-0.23

Cash Flow Statement

Operating Cash Flow (ttm)-358.69k
Levered Free Cash Flow (ttm)-115.85k